Identification and Clinical Characterization of a Novel Alpha-Galactosidase A Mutation
Journal of Inborn Errors of Metabolism and Screening · 2014
DOI: 10.1177/2326409814554700 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Inborn Errors of Metabolism and Screening, 2014. Verfasst von Nilton Salles Rosa Neto. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben.
Abstract (Originalsprache)
Fabry disease (FD) is an inborn error of metabolism characterized by deficient/absent activity of lysosomal enzyme alpha-galactosidase A, which results in systemic accumulation of glycosphingolipids and progression to renal failure, heart and cerebrovascular disease, and small-fiber peripheral neuropathy. This article describes a Brazilian family affected by FD caused by a novel mutation in exon 6 of the alpha-galactosidase A (GLA) gene (c.812G>C). Signs and symptoms identified were pain crisis, acroparesthesia, hypohidrosis, abdominal cramps and diarrhea, chronic kidney disease, cornea verticillata, left ventricular hypertrophy, and complete heart block. Headache was a common complaint and 1 of the patients presented with aseptic meningitis. The novel missense mutation in the GLA gene identified in this Brazilian family is consistent with the classic FD phenotype.
Zitieren
APA
Neto, N. S. R. (2014). Identification and Clinical Characterization of a Novel Alpha-Galactosidase A Mutation. Journal of Inborn Errors of Metabolism and Screening. https://doi.org/10.1177/2326409814554700
Vancouver
Neto NSR. Identification and Clinical Characterization of a Novel Alpha-Galactosidase A Mutation. Journal of Inborn Errors of Metabolism and Screening. 2014. doi:10.1177/2326409814554700
BibTeX
@article{Neto2014,
author = {Neto, Nilton Salles Rosa},
title = {Identification and Clinical Characterization of a Novel Alpha-Galactosidase A Mutation},
journal = {Journal of Inborn Errors of Metabolism and Screening},
year = {2014},
doi = {10.1177/2326409814554700}
}
EUVIMED